Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2014
03/12/2014CN102657598B Porous inorganic material based oral preparation of secondary-dispersion insoluble drug and preparation method thereof
03/12/2014CN102614461B Spray for rapidly relieving stenocardia and preparation method thereof
03/12/2014CN102600399B Traditional Chinese medicine for treating chronic annex inflammatory mass and preparation method of traditional Chinese medicine
03/12/2014CN102579367B Topiramate sustained-release drug composition, method for preparing same and application of Topiramate sustained-release drug composition
03/12/2014CN102552464B Oxaprozin and preparation technology thereof
03/12/2014CN102552294B Compound vitamin freeze-dried powder injection for injection
03/12/2014CN102548538B Topical formulation for diabetic foot ulcers
03/12/2014CN102526328B Medicine for treating bone fracture
03/12/2014CN102525876B Aspirin solid dispersion, as well as preparation method, pharmaceutical composition and use thereof
03/12/2014CN102512378B Stable and safe oxiracetam pharmaceutical composition for injection
03/12/2014CN102488774B Chinese medicinal powder for treating canker sore and preparation method thereof
03/12/2014CN102451182B Preparation method of compound pseudoephedrine hydrochloride capsule
03/12/2014CN102448437B Compositions and methods for alleviating hyposalivation and for providing oral comfort
03/12/2014CN102441150B Medicine composition for treating cardiac and pulmonary multi-viscera failure and preparation method thereof
03/12/2014CN102417465B New tigecycline crystal form and preparation method thereof
03/12/2014CN102316860B Film base for adhesive patch, and adhesive patch
03/12/2014CN102302456B Preparation method of tilmicosin phosphate microsphere specifically for use on animals
03/12/2014CN102293753B Coenzyme Q10 nanosuspension freeze-dried composition and preparation method and application thereof
03/12/2014CN102210648B High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
03/12/2014CN102198099B Toltrazuril suspension and preparation method thereof
03/12/2014CN102143761B Agent for treating myelofibrosis
03/12/2014CN102085377B Immunogenic composition and methods
03/12/2014CN102018658B Controlled release preparation and preparation method thereof
03/12/2014CN101927002B Medicament and coating composition
03/12/2014CN101848689B Intrauterine deposit
03/12/2014CN101842088B Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
03/12/2014CN101829269B Compound raidx astragali and chickpea granules and preparation method thereof
03/12/2014CN101642426B Baicalin adhesion type nanometer eye drops and preparation method thereof
03/12/2014CN101559178B Medicated thread for curing acute nephritis, chronic nephritis and chronic renal failure and application thereof
03/12/2014CN101415406B Calcium phosphate complex in acid containing chewing gum
03/11/2014US8669290 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
03/11/2014US8669284 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
03/11/2014US8669245 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
03/11/2014US8669237 Biodegradable immunomodulatory formulations and methods for use thereof
03/11/2014US8668955 Single step milling and surface coating process for preparing stable nanodispersions
03/11/2014US8668936 Calcium carbonate granulation
03/11/2014US8668935 Method and composition for hyperthermally treating cells
03/11/2014US8668934 Pharmaceutical formulation comprising a water-insoluble active agent
03/11/2014US8668933 Polyion complex of double-stranded ribonucleic acid
03/11/2014US8668932 Extended release venlafaxine formulation
03/11/2014US8668931 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
03/11/2014US8668930 Durable film coating compositions having sustained slow-release capability, and methods of use therefor
03/11/2014US8668929 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
03/11/2014US8668928 Capsule
03/11/2014US8668926 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
03/11/2014US8668925 Transdermal delivery of hormones without the need of penetration enhancers
03/11/2014US8668923 Filmy compositions
03/11/2014US8668902 Composition with activated carbon in oral treatment
03/11/2014US8668901 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
03/11/2014US8668676 Apparatus and methods for implanting particulate ocular implants
03/11/2014CA2748620C Naltrexone hydrochloride compositions
03/11/2014CA2648280C Controlled release delivery device comprising an organosol coat
03/11/2014CA2646667C Methods of treating hot flashes with formulations for transdermal or transmucosal application
03/11/2014CA2631821C Pre-compacted calcium-containing compositions
03/11/2014CA2572106C Low temperature drying methods for forming drug-containing polymeric compositions
03/11/2014CA2533358C Antibiotic product, use and formulation thereof
03/11/2014CA2533178C Antibiotic product, use and formulation thereof
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/06/2014WO2014036555A1 Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin
03/06/2014WO2014036534A1 Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
03/06/2014WO2014036323A1 Method and composition for treating hyperglycemia
03/06/2014WO2014036290A1 Drug delivery devices and methods of making and using same
03/06/2014WO2014036210A1 Foot implant and method for treating plantar fasciitis
03/06/2014WO2014036194A1 Polymeric nanocarriers with light-triggered release mechanism
03/06/2014WO2014035798A1 Silk lyogels for sustained release of protein therapeutics and methods of making and uses
03/06/2014WO2014035451A1 Ophthalmic compositions with wax esters
03/06/2014WO2014035450A1 Ophthalmic compositions with omega-3 fatty acids
03/06/2014WO2014035356A1 Tablet formulations comprising a quinone derivative active agent
03/06/2014WO2014035355A1 Pharmaceutical combination comprising idebenone and memantine
03/06/2014WO2014035295A1 Pharmaceutical composition for treating gastro-oesophageal reflux disease
03/06/2014WO2014035219A1 Dosage form for oral administration capable of being adhered to flowing gastric mucosa
03/06/2014WO2014035190A1 Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
03/06/2014WO2014035188A1 Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate
03/06/2014WO2014034939A1 Adhesive skin patch
03/06/2014WO2014034929A1 Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
03/06/2014WO2014034884A1 Cryopreservable cell scaffold material
03/06/2014WO2014034860A1 Orally administered medical composition
03/06/2014WO2014034669A1 Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
03/06/2014WO2014034548A1 Method for producing seamless capsule
03/06/2014WO2014034046A1 Vaccine formulation against toxoplasma gondii infection
03/06/2014WO2014033744A2 A novel pharmaceutical composition of linezolid
03/06/2014WO2014033526A1 Pharmaceutical compositions of etoricoxib
03/06/2014WO2014033453A1 Nanoparticle formulation
03/06/2014WO2014033346A1 System for transporting biologically active molecules, comprising a nanoparticle, a peptide and a biologically active molecule
03/06/2014WO2014033291A1 Pharmaceutical compositions comprising an active agent
03/06/2014WO2014033230A1 Compositions for oral administration to animals, production methods thereof and uses of same
03/06/2014WO2014033187A1 Finely divided particles of core-shell structure
03/06/2014WO2014033077A1 Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets
03/06/2014WO2014032956A1 Tigecycline formulations
03/06/2014WO2014032953A1 Formulation for the delivery of nucleotide sequences that can modulate endogenous interfering rna mechanisms
03/06/2014WO2014032780A1 Hybrid hydrogels
03/06/2014WO2014032742A1 Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
03/06/2014WO2014032741A1 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
03/06/2014WO2014032676A1 A solid oral formulation for treatment and/or prevention of overweight and/or for stabilizing blood sugar levels in an individual.
03/06/2014WO2014032152A1 Polymeric finasteride and minoxidil nanoparticles, method for preparing same, aqueous suspension containing same, pharmaceutical composition and use thereof
03/06/2014WO2014032151A1 Polymeric finasteride nanoparticle, aqueous composition containing same, composition for the treatment of alopecia, method for preparing said composition, and use thereof
03/06/2014WO2014032108A1 Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions
03/06/2014WO2014011083A3 Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same
03/06/2014WO2014001267A3 Medicament form for release of active ingredients
03/06/2014WO2013184646A3 Dosing regimens for subcutaneously infusible acidic compositions
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 2991